CA1067076A - Pyrimidone derivatives - Google Patents

Pyrimidone derivatives

Info

Publication number
CA1067076A
CA1067076A CA262,162A CA262162A CA1067076A CA 1067076 A CA1067076 A CA 1067076A CA 262162 A CA262162 A CA 262162A CA 1067076 A CA1067076 A CA 1067076A
Authority
CA
Canada
Prior art keywords
methyl
pyrimidone
imidazolylmethylthio
ethylamino
methylthio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA262,162A
Other languages
English (en)
French (fr)
Inventor
Thomas H. Brown
Graham J. Durant
John C. Emmett
Charon R. Ganellin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Application granted granted Critical
Publication of CA1067076A publication Critical patent/CA1067076A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA262,162A 1975-10-02 1976-09-28 Pyrimidone derivatives Expired CA1067076A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4034175 1975-10-02

Publications (1)

Publication Number Publication Date
CA1067076A true CA1067076A (en) 1979-11-27

Family

ID=10414412

Family Applications (1)

Application Number Title Priority Date Filing Date
CA262,162A Expired CA1067076A (en) 1975-10-02 1976-09-28 Pyrimidone derivatives

Country Status (36)

Country Link
JP (2) JPS5246087A (ko)
AR (1) AR221682A1 (ko)
AT (1) AT358045B (ko)
AU (1) AU504897B2 (ko)
BE (1) BE846452A (ko)
BG (1) BG25224A3 (ko)
CA (1) CA1067076A (ko)
CH (1) CH625801A5 (ko)
CS (1) CS203003B2 (ko)
DD (1) DD126563A5 (ko)
DE (1) DE2643670C2 (ko)
DK (1) DK442476A (ko)
ES (1) ES452060A1 (ko)
FI (1) FI61701C (ko)
FR (1) FR2326192A1 (ko)
GR (1) GR61307B (ko)
HU (1) HU175537B (ko)
IE (1) IE44845B1 (ko)
IL (1) IL50503A (ko)
IN (1) IN146736B (ko)
IT (2) IT1070839B (ko)
LU (1) LU75922A1 (ko)
MW (1) MW3476A1 (ko)
MX (1) MX4614E (ko)
NL (1) NL7609917A (ko)
NO (1) NO145792C (ko)
NZ (1) NZ181959A (ko)
OA (1) OA05445A (ko)
PH (1) PH13921A (ko)
PL (1) PL105828B1 (ko)
PT (1) PT65590B (ko)
RO (1) RO73511A (ko)
SE (1) SE431872B (ko)
YU (1) YU237276A (ko)
ZA (1) ZA765498B (ko)
ZM (1) ZM12176A1 (ko)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MW5076A1 (en) * 1975-12-29 1978-02-08 Smith Kline French Lab Pharmacologicalle active compounds
NZ186511A (en) 1977-03-19 1980-11-14 Smith Kline French Lab 3-substituted alkylamino-6-substituted alkyl-1,2,4-triazin-5-ones and pharmaceutical compositions 3-substituted thio-1,2,4-triazin-5-ones
NZ186965A (en) 1977-04-20 1980-02-21 Ici Ltd Guanidino derivatives and pharmaceutical compositions
US4165378A (en) 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
JPS54104816A (en) * 1978-01-27 1979-08-17 Memorex Corp Magnetic recorder tape reel
IN151188B (ko) * 1978-02-13 1983-03-05 Smith Kline French Lab
AU527202B2 (en) * 1978-04-11 1983-02-24 Smith Kline & French Laboratories Limited 2-aminopyrimidones
IL57416A (en) * 1978-05-30 1983-03-31 Smith Kline French Lab Nitro compounds,processes for preparing them and compositions containing them
ZA793443B (en) * 1978-07-26 1980-12-31 Glaxo Group Ltd Heterocyclic derivatives
US4374836A (en) 1978-10-16 1983-02-22 Imperial Chemical Industries Ltd. Antisecretory heterocyclic derivatives, process for their manufacture and pharmaceutical compositions containing them
US4496567A (en) * 1978-11-13 1985-01-29 Smith Kline & French Laboratories Limited Phenyl alkylaminopyrimidones
US4521418A (en) * 1979-02-21 1985-06-04 Smith Kline & French Laboratories Limited Guanidinothiazolyl derivatives
JPS55145683A (en) * 1979-04-26 1980-11-13 Smith Kline French Lab Pyrimidone derivative
CA1155842A (en) * 1980-03-29 1983-10-25 Thomas H. Brown Compounds
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
IE53068B1 (en) * 1981-06-15 1988-05-25 Merck & Co Inc Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors
PT75074B (en) * 1981-06-27 1986-02-26 Smith Kline French Lab Process for preparing certain pyrimidone derivatives and compositions containing them
CA1206151A (en) * 1981-12-28 1986-06-17 Richard P. Pioch Pyrimidone anti-ulcer agents
JPS5993074A (ja) * 1982-10-01 1984-05-29 スミス・クライン・アンド・フレンチ・ラボラトリ−ス・リミテツド ピリミドン誘導体
DE8309239U1 (de) * 1983-03-29 1983-09-29 Basf Ag, 6700 Ludwigshafen Bandspule, insbesondere fuer magnetbaender

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1397436A (en) * 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them

Also Published As

Publication number Publication date
FI762803A (ko) 1977-04-03
YU237276A (en) 1983-01-21
FR2326192B1 (ko) 1979-01-12
MW3476A1 (en) 1977-11-09
IN146736B (ko) 1979-08-25
DE2643670C2 (de) 1982-07-01
BG25224A3 (en) 1978-08-10
NZ181959A (en) 1978-07-28
ATA711976A (de) 1980-01-15
MX4614E (es) 1982-07-07
PL105828B1 (pl) 1979-11-30
OA05445A (fr) 1981-03-31
DK442476A (da) 1977-04-03
AT358045B (de) 1980-08-11
AU1829576A (en) 1978-04-06
IE44845L (en) 1977-04-02
CH625801A5 (en) 1981-10-15
JPS5635674B2 (ko) 1981-08-19
ES452060A1 (es) 1977-10-01
PT65590B (en) 1978-03-28
LU75922A1 (ko) 1977-05-06
IL50503A0 (en) 1976-11-30
GR61307B (en) 1978-10-19
PH13921A (en) 1980-11-04
CS203003B2 (en) 1981-02-27
BE846452A (fr) 1977-03-22
DE2643670A1 (de) 1977-04-14
NO145792B (no) 1982-02-22
ZA765498B (en) 1977-08-31
RO73511A (ro) 1981-04-30
IL50503A (en) 1980-12-31
IT1070839B (it) 1985-04-02
ZM12176A1 (en) 1977-07-21
AR221682A1 (es) 1981-03-13
FI61701B (fi) 1982-05-31
PT65590A (en) 1976-10-01
NO145792C (no) 1982-06-02
IE44845B1 (en) 1982-04-21
NO763371L (ko) 1977-04-05
JPS5246087A (en) 1977-04-12
IT7830708A0 (it) 1978-12-11
JPS609755B2 (ja) 1985-03-12
FI61701C (fi) 1982-09-10
NL7609917A (nl) 1977-04-05
AU504897B2 (en) 1979-11-01
SE7610409L (sv) 1977-04-03
DD126563A5 (ko) 1977-07-27
HU175537B (hu) 1980-08-28
SE431872B (sv) 1984-03-05
JPS5695186A (en) 1981-08-01
FR2326192A1 (fr) 1977-04-29

Similar Documents

Publication Publication Date Title
CA1067076A (en) Pyrimidone derivatives
US4159329A (en) 4-Pyrimidones compositions, and methods of use
EP0163324B1 (en) Aminoalkylphenoxy derivatives
EP0003677B1 (en) Pyrimidones, processes for their preparation and pharmaceutical compositions containing them
US4101548A (en) 1,2,3-Thiadiazole amides
US4171363A (en) 1,2,3-Thiadiazole process
US3780040A (en) 2-substituted-3,4-dihydroquinazolines
CA1175432A (en) N-oxacyclyl-alkylpiperidine derivatives, process for their preparation, pharmaceutical products containing them, and their use
EP0161841B1 (en) 2-(n-substituteguanidino)-4-hetero-arylthiazole antiulcer agents
US4524071A (en) Pyrimidone derivatives
CS216927B2 (en) Method of making the new aminothiazole derivatives
HU184259B (en) Process for producing 2-imidazoline derivatives
EP0015138B1 (en) Pyrimidone derivatives, processes for their preparation and pharmaceutical compositions containing them
US4218452A (en) Substituted 4-pyrimidone compounds, compositions and methods of use
EP0004793B1 (en) 2-nitro aminopyrimidone derivatives, a process for their preparation and their use to prepare 2-aminopyrimidone derivatives which have histamine h2-antagonist activity
US4496567A (en) Phenyl alkylaminopyrimidones
US4185103A (en) Pharmacologically active triazinones
EP0173377A2 (en) Pyrimidone compounds, their preparation and pharmaceutical compositions containing them
US4397849A (en) Benzothiazine derivatives
US4468399A (en) 2-[2-(2-Aminoalkyl-4-thiazolylmethylthio)alkyl]-amino-5-substituted-4-pyrimidones
US4539207A (en) Pyrimidine compounds
GB1595291A (en) Pyrimidone and thiopyrimidone derivatives
US4649142A (en) 3,4-dihydro-1,3-disubstituted-6-(substituted phenylimino)-2(1H)-pyrimidinone useful as cardiotonic agent and anti-allergic agent
GB2111995A (en) Improvements in or relating to anti-ulcer drugs
GB1601132A (en) Pharmacologically active triazinones